Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

sodrock,

The new rules are coming from the Obamacare legislation with one of the reasons being cost. As we know, if competition is limited or if the competition has to pay enormous amounts in bringing a drug to market the cost savings won't be meaningful.

Sooner or later we won't have a choice and someone in Washington will figure out that the costs have to come down and they'll pull out all the stops to obtain it.

Very soon, Washington will be picking up more and more of the healthcare tab and as they go broke they'll have two choices, deny the use of a drug itself or offer a knockoff.